Tuberculosis Vaccine Market – Global Trends, 2026
Tuberculosis (TB) is a highly contagious disease caused by the bacterium known as Mycobacterium tuberculosis and is mostly spread through person to person contact. It causes multisystem infection and eventually might lead to death of the infected person. Two types of TB that are commonly observed include latent TB in which the infected person do not show symptoms and active TB in which the infected person shows clinical symptoms of TB. Clinical symptoms and signs of TB include fever, night sweats, cough, weight loss, hemoptysis (coughing up blood-stained sputum), fatigue, chest pain, and shortness of breath. Depending upon the symptoms, TB may be classified as pulmonary TB, subcutaneous TB or military TB.
Tuberculosis (TB) is a highly contagious disease caused by the bacterium known as Mycobacterium tuberculosis and is mostly spread through person to person contact. It causes multisystem infection and eventually might lead to death of the infected person. Two types of TB that are commonly observed include latent TB in which the infected person do not show symptoms and active TB in which the infected person shows clinical symptoms of TB. Clinical symptoms and signs of TB include fever, night sweats, cough, weight loss, hemoptysis (coughing up blood-stained sputum), fatigue, chest pain, and shortness of breath. Depending upon the symptoms, TB may be classified as pulmonary TB, subcutaneous TB or military TB.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REPORT DESCRIPTION<br />
<strong>Tuberculosis</strong> <strong>Vaccine</strong> <strong>Market</strong> <strong>–</strong> Overview<br />
<strong>Tuberculosis</strong> (TB) is a highly contagious disease caused by the bacterium known as Mycobacterium tuberculosis and is<br />
mostly spread through person to person contact. It causes multisystem infection and eventually might lead to death of<br />
the infected person. Two types of TB that are commonly observed include latent TB in which the infected person do<br />
not show symptoms and active TB in which the infected person shows clinical symptoms of TB. Clinical symptoms<br />
and signs of TB include fever, night sweats, cough, weight loss, hemoptysis (coughing up blood-stained sputum),<br />
fatigue, chest pain, and shortness of breath. Depending upon the symptoms, TB may be classified as pulmonary TB,<br />
subcutaneous TB or military TB.<br />
Depending on the resistance it shows, TB may be multidrug resistant TB or extended drug resistant TB. Diagnosis of<br />
tuberculosis can be carried out using skin test, polymerase chain reaction test or interferon-gamma release assays.<br />
Initial treatment regime for active TB includes drugs such as ethambutol, pyrazinamide, isoniazid, and rifampicin.<br />
Although currently no TB vaccine is approved commercially, children are vaccinated with BCG vaccine as a part of<br />
precautionary measure. However, BCG vaccine has limited utility and variable efficacy in both adults and children.<br />
Many TB vaccines are under the stage of clinical development, which are expected to reach the market in the near<br />
future.<br />
Click To Continue Reading on <strong>Tuberculosis</strong> <strong>Vaccine</strong> <strong>Market</strong><br />
© Coherent market Insights. All Rights Reserved
Change language